Alamar Biosciences, a portfolio company of Qiming Venture Partners and a global leader in precision proteomics, successfully listed on the NASDAQ Stock Exchange on April 17th, 2026, Beijing Time.
Understanding The Robotics Landscape The Current State of Robotics Robots aren’t just science fiction anymore; they’re ...